Get Updates

No one should face hereditary cancer alone.

Thinking about cancer or dealing with cancer risk can be scary or overwhelming, but we believe that receiving information and resources is comforting, empowering, and lifesaving.

Hereditary Cancer Info > Cancer Treatment > PARP Inhibitor Therapy

| More

Toggle Menu

PARP Inhibitor Therapy

Learn how genetic test results may affect medical decisions about cancer treatment.”

Veliparib for Pancreatic Cancer

Veliparib is a PARP inhibitor being studied for treating pancreatic cancer. There is randomized phase II clinical trial recruiting people with a BRCA1, BRCA2 or PALB2 mutation studying how well veliparib together with gemcitabine hydrochloride and cisplatin works compared to gemcitabine hydrochloride and cisplatin alone in treating patients with pancreatic cancer that has spread from where it started to nearby tissue or lymph nodes (locally advanced) or spread from the primary site (place where it started) to other places in the body (metastatic). 

Updated 12/23/16

FORCE:Facing Our Risk of Cancer Empowered